# Frontida Biopharm, LLC – FDA Inspection, Oct 24, 2025

Source: https://www.keypedia.com/records/fda_inspections/frontida-biopharm-llc/e7bdf618-1f6a-4a66-b243-95bdbeb8f6c8
Source feed: FDA_Inspections

> FDA inspection 1283762 of Frontida Biopharm, LLC, October 24, 2025. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1283762
- Company Name: Frontida Biopharm, LLC
- Inspection Date: 2025-10-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Chicago District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1137467 - 2021-02-26](https://www.keypedia.com/records/fda_inspections/frontida-biopharm-llc/95354c58-9f97-48e1-9f28-5f91a3cabce0)
- FDA Inspection 961359 - 2016-02-18
- FDA Inspection 820917 - 2013-02-26
- FDA Inspection 739828 - 2011-08-16
- FDA Inspection 637304 - 2010-01-05

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/angela-c-welker/b732b19f-c8e8-43b0-bc81-8dcde8a53c84)

Company: https://www.keypedia.com/companies/frontida-biopharm-llc/cf64a5c6-28c6-49c7-b4d2-b12b1339c2e5

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669
